cisapride has been researched along with disopyramide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Jia, L; Sun, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sen, S; Sinha, N | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Akima, M; Azumi, T; Fukuzaki, H; Inatome, T; Kuroda, T; Nakamura, H; Takanashi, H; Yogo, K; Yoshihara, Y | 1 |
| Batzias, G; Kounenis, G; Koutsoviti-Papadopoulou, M | 1 |
| Batzias, GC; Kounenis, G; Koutsoviti-Papadopoulou, M; Nikolaidis, E | 1 |
11 other study(ies) available for cisapride and disopyramide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
Effects of cisapride on gastrointestinal motor activity and gastric emptying of disopyramide.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cisapride; Disopyramide; Dogs; Drug Synergism; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Injections, Intravenous; Male; Middle Aged; Piperidines; Serotonin Antagonists | 1992 |
Cisapride counteracts the anticholinergic effect of disopyramide on the guinea pig isolated small but not large intestine.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Cisapride; Disopyramide; Drug Interactions; Female; Gastrointestinal Agents; Gastrointestinal Motility; Guinea Pigs; In Vitro Techniques; Intestine, Large; Intestine, Small; Male | 1998 |
Cisapride reverses the anticholinergic effect of disopyramide on the isolated guinea-pig urinary bladder.
Topics: Acetylcholine; Animals; Cholinergic Antagonists; Cisapride; Disopyramide; Dose-Response Relationship, Drug; Drug Interactions; Female; Gastrointestinal Agents; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth; Parasympathetic Nervous System; Parasympatholytics; Urinary Bladder | 2002 |